Update on medical management of Peyronie's disease

Curr Urol Rep. 2014 Jun;15(6):415. doi: 10.1007/s11934-014-0415-4.

Abstract

The treatment of Peyronie's disease (PD) is a challenge for the clinician. In the quest to straighten the penis, alleviate pain, prevent further shortening, and restore erectile function, many non-surgical treatments have been offered in lieu of an operative approach, which is still considered the gold standard for definitive treatment. This communication is an update on the different approaches used in the minimally invasive management of this frustrating and yet intriguing condition.

Publication types

  • Review

MeSH terms

  • 4-Aminobenzoic Acid / therapeutic use*
  • Administration, Topical
  • Adrenal Cortex Hormones / therapeutic use
  • Disease Management
  • High-Energy Shock Waves / therapeutic use*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Iontophoresis / methods*
  • Male
  • Penile Induration / therapy*
  • Pentoxifylline / therapeutic use
  • Radiotherapy / methods*
  • Recombinant Proteins / therapeutic use
  • Stem Cell Transplantation / methods*
  • Traction / methods
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / therapeutic use
  • Vasodilator Agents / therapeutic use*
  • Verapamil / therapeutic use
  • Vitamin E / therapeutic use
  • Vitamins / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Vasodilator Agents
  • Vitamins
  • Ubiquinone
  • Vitamin E
  • Verapamil
  • coenzyme Q10
  • Pentoxifylline
  • 4-Aminobenzoic Acid